Showing results (101-110 of 142) with videos related to
Sort By:
Pageof 15
Cancers|November 6, 2019
Dual PDK1/Aurora Kinase A Inhibitors Reduce Pancreatic Cancer Cell Proliferation and Colony FormationIlaria Casari, Alice Domenichini, Simona Sestito, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|March 25, 2017
Defining the Anti-Cancer Activity of Tricarbonyl Rhenium Complexes: Induction of G2/M Cell Cycle Arrest and Blockade of Aurora-A Kinase PhosphorylationPeter V Simpson, Ilaria Casari, Silvano Paternoster, et al.Cancers|January 24, 2020
Antiplatelet Drug Ticagrelor Enhances Chemotherapeutic Efficacy by Targeting the Novel P2Y12-AKT Pathway in Pancreatic Cancer CellsOmar Elaskalani, Alice Domenichini, Norbaini Binti Abdol Razak, et al.Pharmacological Research|January 8, 2019
Blood-brain barrier disturbances in diabetes-associated dementia: Therapeutic potential for cannabinoidsEmily Brook, John Mamo, Rachel Wong, et al.Advances in Biological Regulation|December 10, 2017
Molecular and cellular mechanisms of chemoresistance in pancreatic cancerAleksandra Adamska, Omar Elaskalani, Aikaterini Emmanouilidi, et al.International Journal of Molecular Sciences|October 14, 2022
Precision Medicine Approaches with Metabolomics and Artificial IntelligenceElettra Barberis, Shahzaib Khoso, Antonio Sica, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 5, 2024
Preclinical pharmacokinetics, pharmacodynamics, and toxicity of novel small-molecule GPR119 agonists to treat type-2 diabetes and obesityMohan Patil, Ilaria Casari, Dinesh Thapa, et al.International Journal of Cancer|July 29, 2011
PI3K class IB controls the cell cycle checkpoint promoting cell proliferation in hepatocellular carcinomaFrancesco Dituri, Antonio Mazzocca, Luigi Lupo, et al.Toxicology and Applied Pharmacology|April 30, 2022
Sex-divergent expression of cytochrome P450 and SIRTUIN 1-7 proteins in toxicity evaluation of a benzimidazole-derived epigenetic modulator in miceYeuan Ting Lee, Yi Jer Tan, Pei Yi Mok, et al.Science (New York, N.Y.)|June 3, 2017
mTORC1 activity repression by late endosomal phosphatidylinositol 3,4-bisphosphateAndrea L Marat, Alexander Wallroth, Wen-Ting Lo, et al.Pageof 15